- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Report predicts strong PET growth
A report by Frost & Sullivan predicts that positron emissiontomography's share of the worldwide market for cancer imagingand therapy equipment will grow rapidly in coming years. PET revenues will constitute 15% of the total market for suchequipment
A report by Frost & Sullivan predicts that positron emissiontomography's share of the worldwide market for cancer imagingand therapy equipment will grow rapidly in coming years.
PET revenues will constitute 15% of the total market for suchequipment by 2000, compared to 1% in 1993. PET's share of revenuesin the cancer imaging and therapy equipment market at that timewill match that of CT, which is expected to decline to 15%, comparedto 24% in 1993.
The market as a whole will grow at a 7% compound annual rate,from $2.74 billion in 1993 to $4.44 billion in 2000, accordingto the report, entitled World Cancer Diagnostic Imaging and TherapeuticEquipment Markets.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
